18F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

18F-FMT Uptake Seen Within Primary Cancer on PET Helps Predict Outcome of Non–Small Cell Lung Cancer

Published:2009-10-16 Issue:11 Volume:50 Page:1770-1776
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kaira Kyoichi,Oriuchi Noboru,Shimizu Kimihiro,Tominaga Hideyuki,Yanagitani Noriko,Sunaga Noriaki,Ishizuka Tamotsu,Kanai Yoshikatsu,Mori Masatomo,Endo Keigo

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Prognostic Factors in Non-small Cell Lung Cancer

2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.

3. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.

4. Non–Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of radiolabeled amino acid tracers in oncologic imaging;Frontiers in Oncology;2023-02-17

2. A Role of Non-FDG Tracers in Lung Cancer?;Seminars in Nuclear Medicine;2022-11

3. Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose;Frontiers in Medicine;2022-10-05

4. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules;PLOS ONE;2022-03-16

5. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics;Pharmacology & Therapeutics;2022-02